Method for treating atrophic age related macular degeneration
US8821870B2 · kind B2 · utility
38Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2008 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Jul 18, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for treating dry age related macular degeneration (dry AMD) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.